Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis
Co-expression of PD-L1-specific chimeric switch receptors (CSRs) improves the antitumor effects of chimeric antigen receptor (CAR) T cells. Here, CSRs are shown to promote the differentiation of mesothelin-targeting CAR T cells into central memory-like cells and improve their efficacy.
Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Nature Portfolio
2022-10-01
|
Серии: | Nature Communications |
Online-ссылка: | https://doi.org/10.1038/s41467-022-33793-w |